Literature DB >> 7897374

Viral load as a determinant for transmission of human papillomavirus type 16 from mother to child.

J N Kaye1, J Cason, F B Pakarian, R J Jewers, B Kell, J Bible, K S Raju, J M Best.   

Abstract

Whilst genital papillomaviruses are commonly believed to be sexually transmitted, transmission of human papillomavirus type 16 (HPV-16) from mother to child at delivery has been described previously [Pakarian et al. (in press) British Journal of Obstetrics and Gynaecology]. In order to determine whether viral load in cervical/vaginal cells was an important determinant of transmission 15 pregnant women with HPV-16 infections were studied. Eight of these women had infants who were positive for HPV-16 DNA at genital and/or buccal sites. Viral load was estimated by laser densitometry of polymerase chain reaction (PCR) products. The eight mothers--four with a previous history of abnormal smears and two with previous genital warts--who transmitted infection to their infants had significantly higher viral loads (P < 0.05) than those who did not. It is concluded that viral load is an important, but not the sole, determinant for the transmission of HPV-16 from mother to infant.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7897374     DOI: 10.1002/jmv.1890440419

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

Review 1.  Guarding against the most dangerous emerging pathogens.

Authors:  P W Ewald
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

2.  Transplacental Transmission of Human Papillomavirus.

Authors:  Anca Florina Zgura; Elvira Bratila; Simona Vladareanu
Journal:  Maedica (Buchar)       Date:  2015-06

Review 3.  Human papillomavirus in infants: transmission, prevalence, and persistence.

Authors:  Delese E LaCour; Connie Trimble
Journal:  J Pediatr Adolesc Gynecol       Date:  2011-05-20       Impact factor: 1.814

4.  High-risk human papillomavirus in the oral cavity of women with cervical cancer, and their children.

Authors:  Rajan Saini; Tan P Khim; Sarah A Rahman; Mazian Ismail; Thean H Tang
Journal:  Virol J       Date:  2010-06-16       Impact factor: 4.099

5.  A novel HPV 16 L1-based chimeric virus-like particle containing E6 and E7 seroreactive epitopes permits highly specific detection of antibodies in patients with CIN 1 and HPV-16 infection.

Authors:  Alberto Monroy-García; Miguel A Gómez-Lim; Benny Weiss-Steider; Georgina Paz-de la Rosa; Jorge Hernández-Montes; Karyna Pérez-Saldaña; Yessica S Tapia-Guerrero; Mariel E Toledo-Guzmán; Edelmiro Santiago-Osorio; Héctor I Sanchez-Peña; María de Lourdes Mora-García
Journal:  Virol J       Date:  2011-02-09       Impact factor: 4.099

6.  The Prevalence of Human Papillomavirus between the Neonates and Their Mothers.

Authors:  Mariusz Skoczyński; Anna Goździcka-Józefiak; Anna Kwaśniewska
Journal:  Biomed Res Int       Date:  2015-12-02       Impact factor: 3.411

7.  Transplacental transmission of Human Papillomavirus.

Authors:  Renato L Rombaldi; Eduardo P Serafini; Jovana Mandelli; Edineia Zimmermann; Kamille P Losquiavo
Journal:  Virol J       Date:  2008-09-25       Impact factor: 4.099

8.  The paediatric story of human papillomavirus (Review).

Authors:  Ioannis N Mammas; George Sourvinos; Demetrios A Spandidos
Journal:  Oncol Lett       Date:  2014-06-04       Impact factor: 2.967

9.  Human papillomavirus (HPV) perinatal transmission and risk of HPV persistence among children: Design, methods and preliminary results of the HERITAGE study.

Authors:  Helen Trottier; Marie-Hélène Mayrand; François Coutlée; Patricia Monnier; Louise Laporte; Joseph Niyibizi; Ana-Maria Carceller; William D Fraser; Paul Brassard; Jacques Lacroix; Diane Francoeur; Marie-Josée Bédard; Isabelle Girard; François Audibert
Journal:  Papillomavirus Res       Date:  2016-07-12

10.  Detection of human papillomavirus in branchial cleft cysts.

Authors:  Taro Ikegami; Takayuki Uehara; Zeyi Deng; Shunsuke Kondo; Hiroyuki Maeda; Asanori Kiyuna; Shinya Agena; Hitoshi Hirakawa; Yukashi Yamashita; Akira Ganaha; Mikio Suzuki
Journal:  Oncol Lett       Date:  2018-05-30       Impact factor: 2.967

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.